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OBJECTIVES We sought to perform a direct comparison between perfusion scintigraphic results and
intracoronary-derived hemodynamic variables (fractional flow reserve [FFR]; absolute and
relative coronary flow velocity reserve [CFVR and rCFVR, respectively]) in patients with
two-vessel disease.
BACKGROUND There is limited information on the diagnostic accuracy of intracoronary-derived variables
(CFVR, FFR and rCFVR) in patients with multivessel disease.
METHODS Dipyridamole technetium-99m sestambi (MIBI) single-photon emission computed tomog-
raphy (SPECT) was performed in 127 patients. The presence of reversible perfusion defects
in the region of interest was determined. Within one week, angiography was performed;
CFVR, rCFVR and FFR were determined in 161 coronary lesions after intracoronary
administration of adenosine. The predictive value for the presence of reversible perfusion
defects on MIBI SPECT of CFVR, rCFVR and FFR was evaluated by the area under the
curve (AUC) of the receiver operating characteristics curves.
RESULTS The mean percentage diameter stenosis was 57% (range 35% to 85%), as measured by
quantitative coronary angiography. Using per-patient analysis, the AUCs for CFVR (0.70 6
0.052), rCFVR (0.72 6 0.051) and FFR (0.76 6 0.050) were not significantly different (p 5
NS). The percentages of agreement with the results of MIBI SPECT were 76%, 78% and
77% for CFVR, rCFVR and FFR, respectively. Per-lesion analysis, using all 161 measured
lesions, yielded similar results.
CONCLUSIONS The diagnostic accuracy of three intracoronary-derived hemodynamic variables, as compared
with the results of perfusion scintigraphy, is similar in patients with two-vessel coronary artery
disease. Cut-off values of 2.0 for CFVR, 0.65 for rCFVR and 0.75 for FFR can be used for
clinical decision-making in this patient cohort. Discordant results were obtained in 23% of
the cases that require prospective evaluation for appropriate patient management. (J Am Coll
Cardiol 2001;37:1316–22) © 2001 by the American College of Cardiology
Decisions regarding intracoronary interventions should be
based on objective evidence of functional significance of
coronary artery narrowings. Therefore, documentation of
myocardial ischemia related to the culprit lesion is impor-
tant for clinical decision-making. Noninvasive diagnostic
tests, such as perfusion scintigraphy, are widely applied for
evaluation of coronary artery disease. However, perfusion
scintigraphy has a limited capability, particularly in mul-
tivessel disease, to assign the perfusion defect to a specific
epicardial coronary narrowing, especially in the so-called
“watershed regions.” The introduction of guide wires,
equipped with pressure or Doppler sensors, allows selective
hemodynamic evaluation of coronary narrowings (1,2). Val-
idation studies of fractional flow reserve (FFR), based on
intracoronary pressure measurements, and coronary flow
velocity reserve (CFVR), based on intracoronary Doppler
flow measurements, demonstrated good agreement with the
results of perfusion scintigraphy, both in severely and
intermediately narrowed coronary arteries (3–8). These
studies were performed predominantly in patients with
single-vessel disease. It has been postulated that FFR is a
more lesion-specific variable, whereas CFVR is determined
by the resistance of both the epicardial coronary narrowing
and the distal microvascular bed (9,10). Consequently, it
can be anticipated that these intracoronary variables may
yield conflicting results. However, a direct comparison of
pressure and flow-derived indexes has only been performed
in a small cohort of patients with single-vessel disease (11).
The purpose of this study was to compare the predictive
value of CFVR, relative coronary flow velocity reserve
(rCFVR) and FFR for the detection of reversible defects, as
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assessed by perfusion scintigraphy, in a large cohort of
patients with two-vessel disease.
METHODS
Study group. Patients with two-vessel coronary artery dis-
ease and stable angina (Canadian Cardiovascular Society
[CCS] classes I–III) or unstable angina (Braunwald’s class I
or II) were eligible for inclusion in this study. Furthermore,
an angiographically normal reference vessel had to be
available. A total of 127 patients were prospectively studied.
Exclusion criteria included factors precluding dipyridamole
infusion and/or assessment of intracoronary measurements
(e.g., occlusions, coronary anatomy) and factors influencing
coronary hemodynamic variables (e.g., left ventricular hy-
pertrophy, severe valvular heart disease, cardiomyopathy,
insulin-dependent diabetes, Q-wave myocardial infarction
in the region of interest, previous coronary artery bypass
graft surgery of the segment of interest).
Study protocol. All patients underwent dipyridamole myo-
cardial perfusion scintigraphy within one week before an-
giography, during which time intracoronary measurements
were performed. Patients had two coronary artery narrow-
ings, resulting in a total of 254 lesions. In 59 lesions (23%),
intracoronary measurements were not performed per the
operator’s interpretation (e.g., technically impossible, total
coronary occlusions, lesion location). In 34 severe lesions
(13%), it was not possible to measure both flow velocity and
pressure. Thus, both flow velocity- and pressure-derived
hemodynamic variables were measured in 161 lesions. An-
gioplasty of the lesions was performed if a reversible defect
was present in the area of interest on sestambi single-photon
emission computed tomography (SPECT) and if the
CFVR, if available, was ,2.0.
This study protocol was approved by the Medical Ethics
Committee of our institution; all patients gave written,
informed consent.
Myocardial perfusion scintigraphy. Single-photon emis-
sion computed tomography was performed using
technetium-99m labeled sestambi (MIBI), according to a
two-day stress/rest protocol. Dipyridamole (0.56 mg/kg
body weight intravenously for 4 min) was used as a
hyperemic agent. Antianginal medication was discontinued
48 h before the stress MIBI SPECT study. All patients
fasted the day of the MIBI SPECT study. Technetium-
99m labeled sestambi (6400 MBq) was injected 4 min after
the start of the administration of dipyridamole, as well as
the next day for the rest images. Single-photon emission
computed tomography was performed using a three-headed
gamma camera equipped with low energy, high resolution
collimators (Siemens, Hoffman Estate, Illinois), starting 1 h
after the administration of MIBI. Acquisition was per-
formed using a 360° noncircular orbit, a 64 3 64 matrix size
and an acquisition time of 60 frames of 45 s. Standard
filtered back projection was performed without applying
attenuation correction. Stress and rest tomographic images
were displayed side by side in the short-axis, horizontal
long-axis and vertical long-axis reconstruction panel.
A panel of experienced nuclear medicine physicians, who
had no knowledge of the angiographic data, evaluated the
scintigraphic images. Stress and rest images were semiquan-
titatively scored as normal or abnormal. Perfusion defects
were classified as dubious, mild, moderate or severe. Im-
provement at rest of more than one grade was considered to
be a “reversible” perfusion defect. Improvement of just one
grade or no improvement was considered to be a “persistent”
perfusion defect. The result was considered “positive” when
a reversible defect was allocated to the perfusion territory of
the coronary artery of interest. Defects located in the
anterior wall and septal region were allocated to the left
anterior descending coronary artery (LAD); defects in the
lateral wall to the left circumflex coronary artery (LCx); and
inferior defects to the right coronary artery (RCA). Apical
defects were considered to be located in the LAD region,
unless the defect extended to the lateral (LCx) or inferior
(RCA) wall. In the watershed regions, the extension of a
defect to either the anterior wall (LAD), lateral wall (LCx)
or inferior wall (RCA) was decisive for the allocation of a
coronary artery to the vascular bed.
Angiography. All patients were treated with aspirin
(100 mg) before the procedure; heparin (5,000 IU) was
given as an intravenous bolus at the beginning of the
procedure. Coronary angiography, including the intracoro-
nary hemodynamic measurements, was performed accord-
ing to standard procedure by the percutaneous femoral
approach, using a 6F guiding catheter without side holes.
Coronary angiography was performed after the administra-
tion of an intracoronary bolus of nitroglycerin (0.1 mg) in at
least two different, preferably orthogonal, views displaying
each index lesion, with minimal foreshortening and no
vessel overlap. Coronary lesion severity was measured by
quantitative coronary angiography, using the CMS-QCA
software, version 3.32 (MEDIS, Leiden, Netherlands), as
previously described (12). Percent diameter stenosis was
assessed in two views; the most severe one was used in the
analysis.
Intracoronary measurements. At the time of performing
the intracoronary measurements, the observer was not aware
Abbreviations and Acronyms
AUC 5 area under the curve
CFVR and rCFVR 5 coronary flow velocity reserve and
relative coronary flow velocity
reserve, respectively
FFR 5 fractional flow reserve
LAD 5 left anterior descending coronary
artery
LCx 5 left circumflex coronary artery
MIBI 5 technetium-99m labeled sestambi
RCA 5 right coronary artery
ROC 5 receiver operating characteristics
SPECT 5 single-photon emission computed
tomography
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of the results of the MIBI SPECT study. If possible,
intracoronary flow velocity was measured distal to both
lesions and also in an angiographically normal coronary
artery. Exchanging wires was at the operator’s discretion, to
obtain subsequent intracoronary pressure measurements dis-
tal to the lesion(s). An intracoronary bolus of 0.1 mg
nitroglycerin was administered every 30 min. All measure-
ments were performed at baseline and during hyperemia.
Hyperemia was induced by administering an intracoronary
bolus of adenosine (15 mg in the RCA and 20 mg in the left
coronary artery).
Translesional blood flow velocity was measured with a
0.035-cm (0.014-in.) Doppler guide wire (FloWire, En-
dosonics, Rancho Cordova, California). The FloWire was
advanced distal to the stenosis, avoiding placement adjacent
to the side branches. A distance from the stenosis greater
than five times the vessel diameter was maintained to avoid
post-stenotic turbulent flow and to allow full development
of a parabolic flow profile. Distal flow baseline and hyper-
emic velocity data were obtained, and the Doppler signals
were processed by a real-time spectral analyzer, using the
Flowmap (Endosonics) (1). The CFVR was computed as
the ratio of hyperemic to basal average peak blood flow
velocity (13). The CFVR was also obtained in an angio-
graphically normal reference coronary artery. Relative
CFVR was defined as the ratio of CFVR of the narrowed
vessel to CFVR of the reference coronary artery.
Intracoronary pressure was measured with a 0.035-cm
(0.014-in.) pressure guide wire connected to the pressure
console (RADI Medical Systems, Uppsala, Sweden). After
calibration with the pressure console, the accuracy of the
system was verified using the aortic pressure, as measured
through the guiding catheter. The wire was advanced with
the pressure sensor at least 3 cm distal to the lesion. During
maximal hyperemia, FFR was calculated as the ratio of the
mean distal to mean aortic pressure.
Data analysis. Data analysis was performed using the
SPSS 10.0.5 software package for Windows (SPSS Inc.,
1999, Arlington, Virginia). As 34 of the 127 patients
contributed two lesions that were measured with the hemo-
dynamic variables, the intrapatient effects could not be
excluded beforehand. Therefore, we performed a per-
patient analysis instead of a per-lesion analysis. Of the 34
patients with two lesions, one randomly chosen lesion was
used for analysis. Of note, this procedure was repeated eight
times to verify consistency. Furthermore, for completeness,
the results of the per-lesion analysis were also calculated.
The predictive value for the presence of reversible perfu-
sion defects on MIBI SPECT of CFVR, rCFVR and FFR
was evaluated by the area under the curve (AUC) of the
receiver operating characteristic curves. A direct comparison
between of the AUCs of the three variables was performed
by using the software package called ROC Curve Analyzer
(written by R. M. Centor and J. Keightley). Accuracy was
calculated for predefined and widely used cut-off values, as
determined in earlier studies of single-vessel disease (CFVR
2.0, FFR 0.75 and rCFVR 0.65), and for the best cut-off
value of the current data set, defined as the highest sum of
sensitivity and specificity. Furthermore, the kappa statistic
was used to evaluate the cut-off values of the hemodynamic
variables as compared with the results of MIBI SPECT.
Data are presented as the mean value 6 SD, unless
indicated otherwise. Linear regression analysis was used to
compare CFVR, rCFVR and FFR. Continuous data were
compared using the Student t test; binomial data were
compared using the chi-square test. A p value ,0.05 was
considered statistically significant.
RESULTS
The baseline characteristics of the 127 study patients were
73% male and mean age 61 years (range 37 to 80). The
patients had the following risk factors: 70% with a smoking
habit, 33% with hypertension, 58% with hypercholesterol-
emia, 9% with noninsulin-dependent diabetes and 54% with
a positive family history of cardiac disease. Most patients
had moderate to severe anginal complaints (2% in CCS I;
18% in CCS II; 59% in CCS III; 21% in Braunwald’s class
I or II). The patients used cardiac medications as follows:
79% on beta-blockers, 58% on calcium antagonists, 65% on
nitrates, 56% on statins and 19% on angiotensin-converting
enzyme inhibitors. The initial hemodynamic data on the
total 161 lesions measured and the 127 lesions studied for
the per-patient analysis are presented in Table 1. All
patients underwent myocardial perfusion scintigraphy
within one week before cardiac catheterization. In total, a
reversible perfusion defect on MIBI SPECT was found in
52 (32%) of the 161 areas of interest.
Table 1. Angiographic and Hemodynamic Data on the Total
161 Coronary Lesions (n 5 127) and for the Randomly Chosen
127 Lesions for the Per-Patient Analysis
161
Lesions
127
Lesions
Coronary lesions
RCA 51 (32%) 37 (29%)
LAD 76 (47%) 63 (50%)
LCx 34 (21%) 27 (21%)
% DS (range) 57 (35–85) 57 (35–85)
Hemodynamic variables (mean 6 SD)
CFVR 2.21 6 0.76 2.25 6 0.72
b-APV 17.1 6 9.6 16.5 6 8.7
h-APV 36.2 6 17.6 36.7 6 16.1
CFVR reference vessel 2.88 6 0.70 2.90 6 0.65
b-APV 18.3 6 6.9 18.2 6 7.1
h-APV 51.0 6 17.6 50.6 6 17.4
rCFVR 0.79 6 0.27 0.82 6 0.27
FFR 0.75 6 0.18 0.76 6 0.17
Pdistal 73.3 6 18.0 73.2 6 18.3
Paorta 97.1 6 13.6 94.5 6 14.1
No significant differences were present.
b-APV 5 baseline average peak flow velocity; CFVR 5 coronary flow velocity
reserve; DS 5 diameter stenosis; FFR 5 fractional flow reserve; h-APV 5 hyperemic
average peak flow velocity; LAD 5 left anterior descending coronary artery; LCX 5
left circumflex coronary artery; Pdistal 5 pressure distal to lesion during hyperemia;
Paorta 5 aortic pressure during hyperemia; RCA 5 right coronary artery; rCFVR 5
relative coronary flow velocity reserve.
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Using per-patient analysis, the AUC (as measured by
ROC analysis) was 0.70 for CFVR, 0.72 for rCFVR and
0.76 for FFR. Direct comparison of the ROC analysis by
the AUCs of the hemodynamic variables did not differ
significantly (CFVR vs. FFR, p 5 0.15; CFVR vs. rCFVR,
p 5 0.27; FFR vs. rCFVR, p 5 0.32). In Table 2, the
accuracy is presented for the best cut-off values and the
predefined cut-off values for the current data set. There were
no significant differences in accuracy, as shown by the 95%
confidence intervals. Kappa values indicated moderate
agreement at determined the best cut-off value (Table 2).
Also, the per-lesion analysis, including all 161 lesions,
yielded similar best cut-off values (1.7 for CFVR, 0.60 for
rCFVR and 0.74 for FFR) and did not reveal significant
differences between the AUCs (0.72 for CFVR, 0.73 for
rCFVR and 0.77 for FFR). The accuracy data were similar
to those of the per-patient analysis, ranging from 68% to
77%. Plots for the sensitivity and specificity of CFVR,
rCFVR and FFR, as calculated with ROC analysis (with the
patient as the unit of analysis), are presented in Figure 1,
A–C. Linear regression analysis of CFVR versus FFR (y 5
0.13x 1 0.48; r 5 0.53; p , 0.001), CFVR versus rCFVR
(y 5 0.24x 1 0.29; r 5 0.62; p , 0.001) and rCFVR versus
FFR (y 5 0.87x 1 0.16; r 5 0.55; p , 0.001) yielded
similar results.
DISCUSSION
This is the first report of a direct comparison between the
results of MIBI SPECT and intracoronary hemodynamic
Table 2. Per-Patient Analysis (n 5 127): Accuracy for CFVR, rCFVR and FFR Versus the
Results of Sestambi Single-Photon Emission Computed Tomography, Calculated for Best and
Predefined Cut-Off Values
Best CV Accuracy 95% CI Kappa
Predefined
CV Accuracy 95% CI Kappa
CFVR 1.7 76%* 68–83 0.40 2.0 69%† 60–76 0.28
rCFVR 0.60 78%* 70–85 0.44 0.65 75%† 66–82 0.37
FFR 0.74 77%* 69–84 0.47 0.75 75%† 66–82 0.43
*†Differences were not statistically significant. The area under the curves for CFVR, rCFVR and FFR (0.70, 0.72 and 0.76,
respectively) did not significantly differ.
CFVR 5 coronary flow velocity reserve; CI 5 confidence interval; CV 5 cut-off value; FFR 5 fractional flow reserve;
rCFVR 5 relative CFVR.
Figure 1. Plots for the sensitivity and specificity of CFVR (A), relative CFVR (B) and FFR (C), as calculated with receiver operating characteristics analysis
on a per-patient basis (n 5 127). The best cut-off value (BCV), defined as the highest sum of sensitivity and specificity, is indicated. CFVR 5 coronary
flow velocity reserve; FFR 5 fractional flow reserve.
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variables in a large cohort of patients (n 5 127) with
two-vessel coronary artery disease. There were no significant
differences in the predictive value of CFVR, rCFVR and
FFR using ROC curves for reversible perfusion defects.
Direct comparisons of CFVR, rCFVR and FFR. The
CFVR is determined by the integrity of both the epicardial
conduit artery and the distal microvascular bed. Relative
CFVR is defined as the ratio of CFVR of the target vessel
to CFVR of the angiographically normal reference coronary
artery, thus theoretically focusing on the contribution of
epicardial narrowing by correcting for microcirculatory dis-
turbances. This concept of rCFVR was introduced by
Gould et al. (13) and validated in experimental and clinical
studies. The concept of FFR was introduced by Pijls and De
Bruyne and colleagues (2,6,9) and was considered to be
independent of hemodynamic and microcirculatory con-
founding factors.
It has been suggested that FFR and rCFVR are more
lesion-specific variables than CFVR (8,14,15). However, in
the present study (n 5 127), we could not demonstrate a
better correlation between rCFVR and FFR (r 5 0.55) than
that between CFVR and FFR (r 5 0.53), suggesting that
the aforementioned confounding factors influencing CFVR
are less pronounced than previously presumed in patients
with coronary artery disease. This interpretation also ex-
plains why rCFVR did not improve the diagnostic accuracy
of CFVR, which is in contrast to the findings of Baumgart
et al. (11) in a small cohort of patients with single-vessel
disease. A uniform CFVR distribution is described in
patients without coronary artery disease (16). However, an
apparently angiographically normal reference artery does
not exclude the presence of atherosclerotic disease. This was
shown in numerous studies using intravascular ultrasound
imaging, where multivessel disease (among other variables)
was an independent predictor of diffuse vessel wall abnor-
malities in angiographically normal reference segments (17).
Heterogeneity of CFVR in the target and reference vessels
in patients with multivessel coronary artery disease could
also explain the failure of rCFVR to improve the relation of
Doppler flow data with FFR in our patient cohort.
Perfusion scintigraphic results versus CFVR, rCFVR
and FFR. Previous validation studies using Doppler or
pressure guide wires were predominantly performed in
patients with single-vessel disease (Table 3), showing cut-
off values of 1.7 to 2.0 for CFVR (3,4,7,8,18,19), 0.65 for
rCFVR (8) and 0.68 to 0.75 for FFR (2,5,6,20). The results
of this study show that the cut-off values validated for
single-vessel disease are in accordance with the values
obtained in two-vessel disease. The practical usefulness of
the intracoronary-derived indexes is reflected in their appli-
cability in a general set of patients. Therefore, currently used
cut-off values in clinical practice (CFVR 2.0; FFR 0.75;
rCFVR 0.65) (9) were compared with those found in the
present study. This study supports the use of a cut-off value
of 0.75 for FFR for clinical decision-making in both single-
and two-vessel disease. Accordingly, a cut-off value of 0.65
can be used for rCFVR in clinical practice. For CFVR, a
cut-off value of 2.0 is widely used for single-vessel disease.
However, the present study reports a best cut-off value of
1.7 for two-vessel disease. As shown in Figure 1A, the
sensitivity is equal for the range of 1.7 to 2.0 in the so-called
“gray zone” (;50% to 55%). Furthermore, several studies
have demonstrated a safe postponement of percutaneous
transluminal coronary angioplasty at CFVR values $2.0
(21–23). These arguments are in favor of using a CFVR
cut-off value of 2.0 for clinical decision-making. Therefore,
we suggest a cut-off value of 2.0 for CFVR in patients with
single- or two-vessel coronary artery disease. As shown in
Table 2, no significant differences were observed in the
accuracy between CFVR, FFR and rCFVR using these
predefined cut-off values.
The aforementioned studies showed 80% to 90% agree-
Table 3. Results of Previous Validation Studies for Intracoronary-Derived CFVR, FFR and
rCFVR Versus the Results of Noninvasive Stress Testing
Author Year (Ref.)
No. of
Patients Noninvasive Stress Test
Reported
Cut-Off Value
CFVR
Miller et al. 1994 (3) 33 SPECT 2.0
Joye et al. 1994 (4) 30 SPECT 2.0
Deychak et al. 1995 (19) 17 SPECT 1.8
Heller et al. 1997 (7) 55 SPECT 1.7
Danzi et al. 1998 (18) 30 Stress echocardiography 2.0
Verberne et al. 1999 (8) 37 SPECT 1.9
FFR
Pijls et al. 1995 (2) 60 Exc.-ECG 0.74
De Bruyne et al. 1995 (5) 60 Exc.-ECG 0.72
Pijls et al. 1996 (6) 45 Exc.-ECG, SPECT and stress
echocardiography
0.75
Bartunek et al. 1997 (20) 37 Stress echocardiography 0.68
rCFVR
Verberne et al. 1999 (8) 37 SPECT 0.65
Exc.-ECG 5 exercise electrocardiography; SPECT 5 single-photon emission computed tomography. Other abbreviations as in
Table 2.
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ment with the results of several noninvasive tests. Our
results of patients with two-vessel disease showed a lower
agreement (;77%) (Table 2) using the best cut-off values.
This may be related to the patient group (i.e., multivessel vs.
single-vessel coronary artery disease). It is known that
perfusion scintigraphy has a limited capability, particularly
in multivessel disease, to assign the perfusion defect to a
specific epicardial coronary narrowing (24). It is possible
that the assignment of the reversible perfusion defect, as
detected by MIBI SPECT, to the perfusion territory of one
of the three main coronary arteries (RCA, LAD and LCx)
was inappropriate, especially in the so-called “watershed
regions.” Knowledge of the anatomic distribution pattern of
the coronary arteries is a prerequisite for appropriate allo-
cation of the culprit coronary artery. However, in this study,
the panel of nuclear medicine physicians and the interven-
tional cardiologist had no knowledge of the angiographic
data and the results of MIBI SPECT, respectively, to ensure
an objective comparison. Finally, hyperemia was differently
induced during scintigraphy (intravenous dipyridamole) and
cardiac catheterization (intracoronary adenosine). Recently,
similar diagnostic accuracy was reported for both exercise
stress testing and administration of adenosine or dipyrida-
mole in inducing maximal hyperemia for myocardial perfu-
sion scintigraphy (25). Furthermore, a recent study showed
no difference in the hyperemic response, as measured by
intracoronary Doppler flow velocity, between adenosine and
adenosine triphosphate (both intravenously and intracoro-
narily administered) in comparison with papavarine (26).
These findings indicate that different agents for vasodilation
and routes of administration were not a major drawback of
the current study.
Study limitations. In this study, 161 of the 254 lesions
were evaluated with CFVR, FFR and rCFVR; thus, 93
lesions were not measured with both intracoronary flow
velocity and pressure. This was related to factors precluding
assessment of intracoronary measurements (e.g., occlusions,
coronary anatomy, lesion location). Because, at present,
intracoronary flow velocity and pressure have to be mea-
sured with two different guide wires, it was at the operator’s
discretion to use both wires in a particular lesion. In general,
the more severe lesions were not suitable for evaluation with
both flow velocity and pressure measurements. Most lesions
studied were of intermediate severity (mean 57% by quan-
titative coronary angiography [range 35% to 85%]). How-
ever, clinical decision-making remains challenging in this
cohort of patients with intermediate lesions, and quantita-
tive coronary angiography is a poor predictor of the occur-
rence of events (27).
The detection of a reversible perfusion defect by perfu-
sion scintigraphy, as well as the allocation of this defect to
a coronary artery, was performed by an experienced panel of
nuclear medicine physicians. In this study, 100 (79%) of the
127 patients (total of 254 lesions) showed one or more
reversible defects on the scintigraphic images. As mentioned
earlier, flow velocity and pressure measurements were per-
formed in 161 of the total 254 lesions. Quantitative coro-
nary angiography of these 161 lesions demonstrated 35% to
85% diameter stenosis. Only 52 (32%) of the 161 areas of
interest were identified by the panel, by allocation of the
perfusion defect to the territory of the culprit coronary
vessel. This could explain the lower agreement found in the
current study between the results of perfusion scintigraphy
and hemodynamic variables.
Clinical implications. The value of intracoronary hemo-
dynamic measurements is important for clinical decision-
making both during elective angiography in patients with
coronary artery disease and in the setting of ad hoc percu-
taneous transluminal coronary angioplasty. This study
shows that CFVR, rCFVR and FFR are three useful
hemodynamic variables for clinical decision-making during
cardiac catheterization in patients with two-vessel coronary
artery disease. The currently used cut-off values for clinical
decision-making in single-vessel disease (CFVR 2.0; FFR
0.75; and rCFVR 0.65) can be applied in patients with
two-vessel disease. In our opinion, FFR is preferable, from
a practical point of view, for clinical decision-making in
patients with coronary artery disease as: 1) the cut-off value
of 0.74 found in the present study is close to the value of
0.75 widely used in single-vessel disease; and 2) FFR is easy
to measure, particularly for inexperienced operators. How-
ever, the present study shows that ROC analysis did not
reveal significant differences between FFR, CFVR and
rCFVR. Long-term follow-up is mandatory in these pa-
tients with discordant results between the invasive indexes
and the results of perfusion scintigraphy to establish which
of these diagnostic methods has the highest clinical rele-
vance from a prognostic point of view.
Acknowledgments
The enthusiastic and skillful help of the paramedical per-
sonnel of the Cardiac Catheterization Laboratory (Head:
Martin Meesterman, RN) and cardiology ward (Head:
Sjouk Boomstra, RN), as well as the technicians of the
department of Nuclear Medicine (Head Technician: Ankie
Lagerwaard), are gratefully acknowledged. Marcel G. W.
Dijkgraaf, PhD, is acknowledged for his useful statistical
comments.
Reprint requests and correspondence: Dr. J. J. Piek, Department
of Cardiology, Room B2-108, Academic Medical Center Amster-
dam, Meibergdreef 9, P.O. Box 22660, 1100 DD, Amsterdam,
The Netherlands. E-mail: s.a.chamuleau@amc.uva.nl.
REFERENCES
1. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler
guide wire for intravascular measurement of coronary artery flow
velocity. Circulation 1992;85:1899–911.
2. Pijls NHJ, Van Gelder B, Van der Voort P, et al. Fractional flow
reserve: a useful index to evaluate the influence of an epicardial
coronary stenosis on myocardial blood flow. Circulation 1995;92:
3183–93.
3. Miller DD, Donohue TJ, Younis LT, et al. Correlation of pharma-
1321JACC Vol. 37, No. 5, 2001 Chamuleau et al.
April 2001:1316–22 Coronary Flow Reserve vs. Perfusion Scintigraphy
cological 99mTc-sestamibi myocardial perfusion imaging with postste-
notic coronary flow reserve in patients with angiographically interme-
diate coronary artery stenoses. Circulation 1994;89:2150–60.
4. Joye JD, Schulman DS, Lasorda D, Farah T, Donohue BC, Reichek
N. Intracoronary Doppler guide wire versus stress single-photon
emission computed tomographic thallium-201 imaging in assessment
of intermediate coronary stenoses. J Am Coll Cardiol 1994;24:940–7.
5. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between
myocardial fractional flow reserve calculated from coronary pressure
measurements and exercise-induced myocardial ischemia. Circulation
1995;92:39–46.
6. Pijls NHJ, De Bruyne B, Peels K, et al. Measurement of fractional flow
reserve to assess the functional severity of coronary-artery stenoses.
N Engl J Med 1996;334:1703–8.
7. Heller LI, Cates C, Popma J, et al., the FACTS Study Group.
Intracoronary Doppler assessment of moderate coronary artery disease:
comparison with 201Tl imaging and coronary angiography. Circulation
1997;96:484–90.
8. Verberne HJ, Piek JJ, van Liebergen RAM, Koch KT, Schroeder-
Tanka JM, van Royen EA. Functional assessment of coronary artery
stenosis by Doppler-derived absolute and relative coronary blood flow
velocity reserve in comparison with Tc-99m MIBI SPECT. Heart
1999;82:509–14.
9. Kern MJ, De Bruyne B, Pijls NH. From research to clinical practice:
current role of intracoronary physiologically based decision making in
the cardiac catheterization laboratory. J Am Coll Cardiol 1997;30:
613–20.
10. Pijls NHJ, De Bruyne B. Coronary pressure measurement and frac-
tional flow reserve. Heart 1998;80:539–42.
11. Baumgart D, Haude M, Goerge G, et al. Improved assessment of
coronary stenosis severity using the relative coronary flow velocity
reserve. Circulation 1998;98:40–6.
12. Van der Zwet PM, Reiber JH. A new approach for the quantification
of complex lesion morphology: the gradient field transform—basic
principles and validation results. J Am Coll Cardiol 1994;24:216–24.
13. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a
physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:
459–74.
14. Kern MJ, Puri S, Bach RG, et al. Abnormal coronary flow velocity
reserve after coronary artery stenting in patients: role of relative
coronary reserve to assess potential mechanisms. Circulation 1999;100:
2491–8.
15. Van Liebergen RAM, Piek JJ, Koch KT, de Winter RJ, Lie KI.
Immediate- and long-term effects of balloon angioplasty or stent
implantation on the absolute and relative coronary blood flow velocity
reserve. Circulation 1998;98:2133–40.
16. Wolford TL, Donohue TJ, Bach RG, et al. Heterogeneity of coronary
flow reserve in the examination of multiple individual allograft coro-
nary arteries. Circulation 1999;99:626–32.
17. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angio-
graphically “normal” coronary artery reference segments: an intravas-
cular ultrasound study with clinical correlations. J Am Coll Cardiol
1995;25:1479–85.
18. Danzi GB, Pirelli S, Mauri L, et al. Which variable of stenosis severity
best describes the significance of an isolated left anterior descending
coronary artery lesion? Correlation between quantitative coronary
angiography, intracoronary Doppler measurements and high dose
dipyridamole echocardiography. J Am Coll Cardiol 1998;31:526–33.
19. Deychak YA, Segal J, Reiner JS, et al. Doppler guide wire flow–
velocity indexes measured distal to coronary stenoses associated with
reversible thallium perfusion defects. Am Heart J 1995;129:219–27.
20. Bartunek J, Van Schuerbeeck E, de Bruyne B. Comparison of exercise
electrocardiography and dobutamine echocardiography with invasively
assessed myocardial fractional flow reserve in evaluation of severity of
coronary arterial narrowing. Am J Cardiol 1997;79:478–81.
21. Ferrari M, Schnell B, Werner GS, Figulla HR. Safety of deferring
angioplasty in patients with normal coronary flow velocity reserve.
J Am Coll Cardiol 1999;33:82–7.
22. Kern MJ, Donohue TJ, Aguirre FV, et al. Clinical outcome of
deferring angioplasty in patients with normal translesional pressure–
flow velocity measurements. J Am Coll Cardiol 1995;25:178–87.
23. Chamuleau SAJ, Tio RA, De Cock CC, et al. Intermediate Lesions:
Intracoronary flow Assessment versus 99mTc-MIBI SPECT (ILIAS
study): a Dutch multicenter study (abstr). Circulation 2000;102 Suppl
II:II477.
24. Travin MI, Katz MS, Moulton AW, Miele NJ, Sharaf BL, Johnson
LL. Accuracy of dipyridamole SPECT imaging in identifying indi-
vidual coronary stenoses and multivessel disease in women versus men.
J Nucl Cardiol 2000;7:213–20.
25. Travin MI, Wexler JP. Pharmacological stress testing. Semin Nucl
Med 1999;29:298–318.
26. De Bruyne B, Pijls NHJ, Wijns W, Bech GJW, Heyndrickx GR.
Intracoronary and intravenous (central vs. peripheral) administration
of ATP and adenosine to induce maximal vasodilation (abstr). Circu-
lation 1999;100 Suppl I:I376.
27. Abizaid AS, Mintz GS, Mehran R, et al. Long-term follow-up after
percutaneous transluminal coronary angioplasty was not performed
based on intravascular ultrasound findings: importance of lumen
dimensions. Circulation 1999;100:256–61.
1322 Chamuleau et al. JACC Vol. 37, No. 5, 2001
Coronary Flow Reserve vs. Perfusion Scintigraphy April 2001:1316–22
